SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

Will Investors Notice Exciting Sign On United Therapeutics's Chart?

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga · 06/10/2022 13:04

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

What To Know: Many traders use moving average crossover systems to make their decisions.

When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.

Why It's Important: The 50-day and the 200-day simple moving averages are commonly used.

The golden cross occurs when the 50-day crosses above the 200-day. This could mean the long-term trend is changing.

That just happened with United Therapeutics, which is trading around $220.22 at publication time.

signals

Remember: Seasoned investors don't blindly trade Golden Crosses.

Instead, they use it as a signal to start looking for long positions based on other factors, like price levels and company fundamentals & events.

For seasoned investors, this is just a sign that it might be time to start considering possible long positions.

With that in mind, take a look at United Therapeutics's past and upcoming earnings expectations:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 3.34 3.72 3.59 3.02
EPS Actual 5.03 3.51 4.16 4.09
Revenue Estimate 420.02M 427.62M 421.45M 378.75M
Revenue Actual 461.90M 415.20M 444.70M 446.50M

Also consider this overview of United Therapeutics analyst ratings:

ratings

Do you use the Golden Cross signal in your trading or investing? Share this article with a friend if you found it helpful!

This article was generated by Benzinga's automated content engine and reviewed by an editor.